Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01489436 · ClinicalTrials.gov registry record · NA

A Comparison of Single Port and Four Port Laparoscopic Gallbladder Removal

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
118
Enrollment target

NCT01489436: Completed NA study, sponsored by Mayo Clinic.

NCT01489436 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 118 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01489436, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
118 participants
Enrollment target

Study Summary

New minimally invasive surgical treatments are often outpatient procedures with low complication rates, promising fast recovery. The traditional physician-reported outcomes such as complication rates, blood loss, and hospital stay are not useful to guide treatment recommendations for one or the other minimally invasive procedure. This study aims to apply patient-reported outcomes developed within the NIH framework for cancer research and chronic disease treatment to the comparative effectiveness research in minimally invasive procedures for benign disease.

Primary Outcome

The investigators will utilize the Patient-Reported Outcomes from the VAS to measure changes from Baseline to day 1 post OP. A 15-mm difference on a 100-mm visual analog scale with a standard deviation of 25 mm at any time point will constitute a clinically relevant difference.

Interventions

  • PROCEDURE Single-port cholecystectomy
  • PROCEDURE Four-port laparoscopic cholecystectomy

Trial Details

FieldValue
Enrollment Target 118 participants
Start Date 2011-07
Est. Completion 2014-03
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT01489436 record still lists

NCT01489436 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Single-port cholecystectomy is the first listed.

NCT01489436 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01489436 about?

NCT01489436 is a clinical study titled "A Comparison of Single Port and Four Port Laparoscopic Gallbladder Removal". New minimally invasive surgical treatments are often outpatient procedures with low complication rates, promising fast recovery. The traditional physician-reported outcomes such as complication rates, blood loss, and hospital stay are not useful to guide treatment recommendations for one or the othe...

What is the current status of trial NCT01489436?

This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2011-07. Estimated completion is 2014-03.

What interventions are being tested in trial NCT01489436?

The interventions under investigation include: Single-port cholecystectomy (PROCEDURE), Four-port laparoscopic cholecystectomy (PROCEDURE).

Who is sponsoring clinical trial NCT01489436?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01489436's enrollment target sits among peer trials

118 803rd of 2000 higher than 1,194 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03821623 · 118 participants · Phase 2

    Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults

  • NCT04040959 · 118 participants · Phase 2

    Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD

  • NCT04696029 · 118 participants · Phase 2

    DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

  • NCT05223192 · 118 participants · NA

    The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01489436, the US trial registry maintained by the National Library of Medicine. NCT01489436 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.